Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive

Journal of Reproductive Immunology

Volumn 110, Issue , 2015, Pages 14-21

  Ngcapu, Sinaye ^a   Masson, Lindi ^a,b   Sibeko, Sengeziwe ^a   Werner, Lise ^a   McKinnon, Lyle R ^a   Mlisana, Koleka ^a   Shey, Muki ^a   Samsunder, Natasha ^a   Karim, Salim Abdool ^a,c   Karim, Quarraisha Abdool ^a,c   Passmore, Jo Ann S ^a,b,d  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Columbia University ^*  (United States)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

Cytokines; DMPA; Hormone contraceptives; MMP; Net EN; TIMP

Indexed keywords

ALPHA INTERFERON; CXCL1 CHEMOKINE; CXCL3 CHEMOKINE; CYTOKINE; EOTAXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FLT3 LIGAND; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INJECTABLE CONTRACEPTIVE AGENT; INTERLEUKIN 12P40; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; INTERLEUKIN 9; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PLATELET DERIVED GROWTH FACTOR AA; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN; CHEMOKINE; COLLAGENASE; CONTRACEPTIVE AGENT; TIMP2 PROTEIN, HUMAN;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; COHORT ANALYSIS; CONDOM USE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE ASSOCIATION; FEMALE; FEMALE GENITAL SYSTEM FUNCTION; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MARRIAGE; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; NONHUMAN; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; VAGINITIS; CASE CONTROL STUDY; CLINICAL TRIAL; IMMUNOLOGY; MICROBIOLOGY; UTERINE CERVIX; VAGINA; VAGINOSIS, BACTERIAL;

ADULT; CASE-CONTROL STUDIES; CERVIX UTERI; CHEMOKINES; COLLAGENASES; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84931088262     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2015.03.007     Document Type: Article

References (41)

1. Abel K., Rourke T., Lu D., Bost K., Mcchesney M.B., Miller C.J. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239. J. Infect. Dis. 2004, 190:1697-1705.
2. Baeten J.M., Nyange P.M., Richardson B.A., Lavreys L., Chohan B., Martin H.L., Mandaliya K., Ndinya-Achola J.O., Bwayo J.J., Kreiss J.K. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am. J. Obstet. Gynecol. 2001, 185:380-385.
3. Baeten J.M., Benki S., Chohan V., Lavreys L., Mcclelland R.S., Mandaliya K., Ndinya-Achola J.O., Jaoko W., Overbaugh J. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007, 21:1771-1777.
4. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 1995, 7:728-735.
5. Bruner K.L., Rodgers W.H., Gold L.I., Korc M., Hargrove J.T., Matrisian L.M., Osteen K.G. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7362-7366.
6. Department of Health, M.R.C., ORCMACRO South Africa Demographic and Health Survey 2003, Pretoria, South Africa 2007.
7. Fernandez-Catalan C., Bode W., Huber R., Turk D., Calvete J.J., Lichte A., Tschesche H., Maskos K. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J. 1998, 17:5238-5248.
8. Fraser I.S., Weisberg E. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. Med. J. Aust. 1981, 1:3-19.
9. Genesca M., Li J., Fritts L., Chohan P., Bost K., Rourke T., Blozis S.A., Mcchesney M.B., Miller C.J. Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239. J. Med. Primatol. 2007, 36:266-275.
10. Ghanem K.G., Shah N., Klein R.S., Mayer K.H., Sobel J.D., Warren D.L., Jamieson D.J., Duerr A.C., Rompalo A.M., Group H.I.V.E.R.S. Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J. Infect. Dis. 2005, 191:358-366.
11. Gillgrass A.E., Ashkar A.A., Rosenthal K.L., Kaushic C. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 2003, 77:9845-9851.
12. Gomis-Ruth F.X., Maskos K., Betz M., Bergner A., Huber R., Suzuki K., Yoshida N., Nagase H., Brew K., Bourenkov G.P., Bartunik H., Bode W. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 1997, 389:77-81.
13. Hannan N.J., Jones R.L., Critchley H.O., Kovacs G.J., Rogers P.A., Affandi B., Salamonsen L.A. Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling. J. Clin. Endocrinol. Metab. 2004, 89:6119-6129.
14. Hatcher R.A., Trussell J., Nelson A.L., Cates W., Kowal D., Policar M. Contraceptive Technology 2011, Ardent Media, New York.
15. Hughes G.C., Thomas S., Li C., Kaja M.K., Clark E.A. Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J. Immunol. 2008, 180:2029-2033.
16. Huijbregts R.P., Helton E.S., Michel K.G., Sabbaj S., Richter H.E., Goepfert P.A., Hel Z. Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms. Endocrinology 2013, 154:1282-1295.
17. Ildgruben A.K., Sjoberg I.M., Hammarstrom M.L. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium. Obstet. Gynecol. 2003, 102:571-582.
18. Jeppsson S., Gershagen S., Johansson E.D., Rannevik G. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Acta Endocrinol. (Copenh.) 1982, 99:339-343.
19. Kiddugavu M., Makumbi F., Wawer M.J., Serwadda D., Sewankambo N.K., Wabwire-Mangen F., Lutalo T., Meehan M., Xianbin, Gray R.H., Rakai Project Study G. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS 2003, 17:233-240.
20. Kleinschmidt I., Rees H., Delany S., Smith D., Dinat N., Nkala B., Mcintyre J.A. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 2007, 75:461-467.
21. Kleynhans L., Du Plessis N., Black G.F., Loxton A.G., Kidd M., Van Helden P.D., Walzl G., Ronacher K. Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users. PLoS ONE 2011, 6:e24639.
22. Kleynhans L., Du Plessis N., Allie N., Jacobs M., Kidd M., Van Helden P.D., Walzl G., Ronacher K. The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis. Infect. Immun. 2013, 81:1234-1244.
23. Kumwenda J.J., Makanani B., Taulo F., Nkhoma C., Kafulafula G., Li Q., Kumwenda N., Taha T.E. Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi. Clin. Infect. Dis. 2008, 46:1913-1920.
24. Lockwood C.J., Schatz F. A biological model for the regulation of peri-implantational hemostasis and menstruation. J. Soc. Gynecol. Investig. 1996, 3:159-165.
25. Miller L., Patton D.L., Meier A., Thwin S.S., Hooton T.M., Eschenbach D.A. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet. Gynecol. 2000, 96:431-439.
26. Mishell D.R., El-Habashy M.A., Good R.G., Moyer D.L. Contraception with an injectable progestin. A study of its use in postpartum women. Am. J. Obstet. Gynecol. 1968, 101:1046-1053.
27. Mlisana K., Naicker N., Werner L., Roberts L., Van Loggerenberg F., Baxter C., Passmore J.A., Grobler A.C., Sturm A.W., Williamson C., Ronacher K., Walzl G., Abdool Karim S.S. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J. Infect. Dis. 2012, 206:6-14.
28. Morrison C.S., Chen P.L., Kwok C., Richardson B.A., Chipato T., Mugerwa R., Byamugisha J., Padian N., Celentano D.D., Salata R.A. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010, 24:1778-1781.
29. Myer L., Denny L., Wright T.C., Kuhn L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int. J. Epidemiol. 2007, 36:166-174.
30. Osteen K.G., Rodgers W.H., Gaire M., Hargrove J.T., Gorstein F., Matrisian L.M. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc. Natl. Acad. Sci. USA 1994, 91(21):10129-10133.
31. Reid S.E., Dai J.Y., Wang J., Sichalwe B.N., Akpomiemie G., Cowan F.M., Delany-Moretlwe S., Baeten J.M., Hughes J.P., Wald A., Celum C. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J. Acquir. Immune Defic. Syndr. 2010, 53:606-613.
32. Rodgers W.H., Osteen K.G., Matrisian L.M., Navre M., Giudice L.C., Gorstein F. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am. J. Obstet. Gynecol. 1993, 168:253-260.
33. Sibeko S., Baxter C., Yende N., Karim Q.A., Karim S.S. Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. Obstet. Gynecol. 2011, 118:895-904.
34. Trunova N., Tsai L., Tung S., Schneider E., Harouse J., Gettie A., Simon V., Blanchard J., Cheng-Mayer C. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology 2006, 352:169-177.
35. Ungchusak K., Rehle T., Thammapornpilap P., Spiegelman D., Brinkmann U., Siraprapasiri T. Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996, 12:500-507.
36. Van De Wijgert J.H., Verwijs M.C., Turner A.N., Morrison C.S. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission. AIDS 2013, 27:2141-2153.
37. Van Loggerenberg F., Dieter A.A., Sobieszczyk M.E., Werner L., Grobler A., Mlisana K. HIV prevention in high-risk women in South Africa: condom use and the need for change. PLoS ONE 2012, 7:e30669.
38. Vincent A.J., Zhang J., Ostör A., Rogers P.A., Affandi B., Kovacs G., Salamonsen L.A. Decreased TIMP in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial MMP/TIMP balance in the pathogenesis of abnormal uterine bleeding?. Hum. Reprod. 2002, 17(5):1189-1198.
39. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83:835-870.
40. Wieser F., Hosmann J., Tschugguel W., Czerwenka K., Sedivy R., Huber J.C. Progesterone increases the number of Langerhans cells in human vaginal epithelium. Fertil. Steril. 2001, 75:1234-1235.
41. Wira C.R., Veronese F. Mucosal immunity in the male and female reproductive tract and prevention of HIV transmission. Am. J. Reprod. Immunol. 2011, 65:182-185.